S H Kelkar (SHK) Aperçu de l'action
S H Kelkar and Company Limited, avec ses filiales, fabrique et fournit des parfums, des arômes et des ingrédients aromatiques en Inde. Plus de détails
| Score flocon de neige | |
|---|---|
| Évaluation | 4/6 |
| Croissance future | 4/6 |
| Performances passées | 0/6 |
| Santé financière | 3/6 |
| Dividendes | 5/6 |
Récompenses
Analyse des risques
SHK Community Fair Values
Create NarrativeSee what 10 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
S H Kelkar and Company Limited Concurrents
Historique des prix et performances
| Historique des cours de bourse | |
|---|---|
| Prix actuel de l'action | ₹135.89 |
| Plus haut sur 52 semaines | ₹255.79 |
| Plus bas sur 52 semaines | ₹111.98 |
| Bêta | 0.33 |
| Variation sur 1 mois | -20.40% |
| Variation sur 3 mois | -1.33% |
| Variation sur 1 an | -45.22% |
| Variation sur 3 ans | -12.61% |
| Variation sur 5 ans | -14.99% |
| Évolution depuis l'introduction en bourse | -34.75% |
Nouvelles et mises à jour récentes
Recent updates
S H Kelkar and Company Limited Just Beat EPS By 228%: Here's What Analysts Think Will Happen Next
It's been a pretty great week for S H Kelkar and Company Limited ( NSE:SHK ) shareholders, with its shares surging 17...
SHK: Upcoming Results And Board Decisions Will Support Further Share Price Upside
Analysts have kept their price target for S H Kelkar broadly unchanged at ₹270.0, citing only marginal tweaks to the discount rate, revenue growth, profit margin and future P/E assumptions that do not materially alter their overall valuation view. What's in the News S H Kelkar has scheduled a board meeting on May 15, 2026, at 17:24 Indian Standard Time to review and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.SHK: Planned Italy Stake Sale Will Support Further Share Price Upside
Analysts have kept the price target for S H Kelkar unchanged at ₹270. This reflects only minor tweaks to inputs such as discount rate, revenue growth assumptions and future P/E in their refreshed valuation work.S H Kelkar's (NSE:SHK) Anemic Earnings Might Be Worse Than You Think
Investors were disappointed by S H Kelkar and Company Limited's ( NSE:SHK ) latest earnings release. We did some...S H Kelkar and Company Limited Just Missed Earnings - But Analysts Have Updated Their Models
There's been a notable change in appetite for S H Kelkar and Company Limited ( NSE:SHK ) shares in the week since its...SHK: Upcoming Stake Sale Will Unlock Further Share Upside Potential
Analysts keep their fair value estimate for S H Kelkar steady at ₹270. This reflects slightly adjusted assumptions for discount rate, revenue growth, profit margin and future P/E, rather than a clear directional shift in the price target itself.SHK: Upcoming Dividend And Stake Sale Will Unlock Share Upside Potential
Analysts have kept the fair value estimate for S H Kelkar steady at ₹270, citing only marginal tweaks to assumptions such as discount rate, revenue growth, profit margin and future P/E that are not large enough to shift the overall price target. What's in the News Board meeting scheduled on Feb 06, 2026, to review unaudited standalone and consolidated financial results for the quarter and nine months ended Dec 31, 2025, consider an interim dividend on equity shares for FY 2025-26, evaluate additional equity investment in Keva Middle East FZE, and address other matters (Key Developments).SHK: Upcoming Dividend And Subsidiary Moves Will Unlock Share Upside Potential
Analysts have kept the S H Kelkar price target steady at ₹270, citing broadly unchanged assumptions on fair value, discount rate, revenue growth, profit margin and future P/E as the basis for this reaffirmation. What's in the News A board meeting is scheduled on February 6, 2026 to review unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, to consider an interim dividend on equity shares for FY 2025-26, to evaluate additional equity investment in Keva Middle East FZE, and to address other matters (company filing).SHK: Upcoming Dividend Decision Will Signal Upside Potential For Shares
Analysts have kept their fair value estimate for S H Kelkar steady at ₹270. They cite only marginal model tweaks to discount rate, revenue growth, profit margin and future P/E that do not materially alter their overall view on the stock.SHK: Board Decisions On Interim Dividend And Subsidiary Funding Will Reveal Value
Analysts have kept their ₹270 price target on S H Kelkar broadly unchanged, reflecting only minor tweaks to assumptions such as a slightly higher discount rate and marginally adjusted revenue growth, profit margin, and future P/E inputs. What's in the News Board meeting scheduled for February 6, 2026, at 16:41 Indian Standard Time to review and approve unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 (company filing).SHK: Lower Margin Outlook Will Highlight Value Ahead Of Interim Dividend
Analysts have reduced their fair value estimate for S H Kelkar from ₹430 to ₹270, reflecting updated assumptions around profit margin compression and a lower future P/E multiple, despite slightly adjusted growth inputs. What's in the News Board meeting scheduled on February 6, 2026 at 16:41 IST to review unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 (company filing).Is S H Kelkar (NSE:SHK) A Risky Investment?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...The Price Is Right For S H Kelkar and Company Limited (NSE:SHK) Even After Diving 26%
To the annoyance of some shareholders, S H Kelkar and Company Limited ( NSE:SHK ) shares are down a considerable 26% in...There May Be Some Bright Spots In S H Kelkar's (NSE:SHK) Earnings
The market was pleased with the recent earnings report from S H Kelkar and Company Limited ( NSE:SHK ), despite the...What You Can Learn From S H Kelkar and Company Limited's (NSE:SHK) P/E
With a price-to-earnings (or "P/E") ratio of 42.7x S H Kelkar and Company Limited ( NSE:SHK ) may be sending very...
Investments In Europe, UK, And USA Will Enhance Product Development And Global Engagement
Strategic investments in Europe, the UK, and the USA are expected to drive revenue growth and enhance S H Kelkar's market presence.The Returns At S H Kelkar (NSE:SHK) Aren't Growing
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Typically...Some Confidence Is Lacking In S H Kelkar and Company Limited's (NSE:SHK) P/S
With a median price-to-sales (or "P/S") ratio of close to 1.4x in the Chemicals industry in India, you could be...Is S H Kelkar (NSE:SHK) A Risky Investment?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...There May Be Reason For Hope In S H Kelkar's (NSE:SHK) Disappointing Earnings
Soft earnings didn't appear to concern S H Kelkar and Company Limited's ( NSE:SHK ) shareholders over the last week...Why Investors Shouldn't Be Surprised By S H Kelkar and Company Limited's (NSE:SHK) 25% Share Price Surge
Despite an already strong run, S H Kelkar and Company Limited ( NSE:SHK ) shares have been powering on, with a gain of...S H Kelkar and Company Limited's (NSE:SHK) 28% Price Boost Is Out Of Tune With Revenues
S H Kelkar and Company Limited ( NSE:SHK ) shareholders have had their patience rewarded with a 28% share price jump in...S H Kelkar's (NSE:SHK) Returns Have Hit A Wall
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect...S H Kelkar and Company Limited's (NSE:SHK) Shareholders Might Be Looking For Exit
There wouldn't be many who think S H Kelkar and Company Limited's ( NSE:SHK ) price-to-earnings (or "P/E") ratio of...Estimating The Fair Value Of S H Kelkar and Company Limited (NSE:SHK)
Key Insights The projected fair value for S H Kelkar is ₹150 based on 2 Stage Free Cash Flow to Equity Current share...S H Kelkar (NSE:SHK) Is Paying Out A Larger Dividend Than Last Year
The board of S H Kelkar and Company Limited ( NSE:SHK ) has announced that it will be paying its dividend of ₹2.00 on...S H Kelkar (NSE:SHK) Has Announced That It Will Be Increasing Its Dividend To ₹2.00
The board of S H Kelkar and Company Limited ( NSE:SHK ) has announced that it will be paying its dividend of ₹2.00 on...Rendement pour les actionnaires
| SHK | IN Chemicals | IN Marché | |
|---|---|---|---|
| 7D | -6.7% | -0.8% | -1.0% |
| 1Y | -45.2% | -1.6% | -1.4% |
Rendement vs Industrie: SHK a sous-performé le secteur Indian Chemicals qui a rapporté -1.6 % au cours de l'année écoulée.
Rendement vs marché: SHK a sous-performé le marché Indian qui a rapporté -1.4 % au cours de l'année écoulée.
Volatilité des prix
| SHK volatility | |
|---|---|
| SHK Average Weekly Movement | 6.6% |
| Chemicals Industry Average Movement | 5.8% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in IN Market | 8.9% |
| 10% least volatile stocks in IN Market | 3.4% |
Cours de l'action stable: SHK n'a pas connu de volatilité de prix significative au cours des 3 derniers mois par rapport au marché Indian.
Volatilité au fil du temps: La volatilité hebdomadaire de SHK ( 7% ) est restée stable au cours de l'année écoulée.
À propos de l'entreprise
| Fondée | Salariés | PDG | Site web |
|---|---|---|---|
| 1922 | 650 | Kedar Vaze | keva.co.in |
S H Kelkar and Company Limited, avec ses filiales, fabrique et fournit des parfums, des arômes et des ingrédients aromatiques en Inde. Ses parfums sont utilisés dans les produits de soins personnels, de soins des tissus, de soins de la peau, de soins des cheveux, de parfums fins et de soins à domicile, ainsi que dans les produits de boulangerie, les produits laitiers, les boissons et les produits pharmaceutiques, et ses arômes sont utilisés dans les produits de boulangerie, les produits laitiers, les boissons et les produits pharmaceutiques. L'entreprise est impliquée dans la microbiologie, la biotechnologie, la cosmétique, la synthèse à façon et la recherche en biotechnologie cosmétique.
S H Kelkar and Company Limited Résumé des fondamentaux
| SHK statistiques fondamentales | |
|---|---|
| Capitalisation boursière | ₹18.81b |
| Bénéfices(TTM) | ₹884.50m |
| Recettes(TTM) | ₹24.49b |
Le site SHK est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
| SHK compte de résultat (TTM) | |
|---|---|
| Recettes | ₹24.49b |
| Coût des recettes | ₹14.44b |
| Marge brute | ₹10.05b |
| Autres dépenses | ₹9.17b |
| Les revenus | ₹884.50m |
Derniers bénéfices déclarés
Jun 30, 2026
Prochaine date de publication des résultats
s/o
| Résultat par action (EPS) | 6.39 |
| Marge brute | 41.05% |
| Marge bénéficiaire nette | 3.61% |
| Ratio dettes/capitaux propres | 75.5% |
Quelles ont été les performances à long terme de SHK?
Voir les performances historiques et les comparaisonsDividendes
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/09/15 18:15 |
| Cours de l'action en fin de journée | 2026/09/15 00:00 |
| Les revenus | 2026/06/30 |
| Revenus annuels | 2026/03/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github ; nous proposons également des guides sur la façon d’utiliser nos rapports et des tutoriels sur YouTube.
Découvrez l' qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
S H Kelkar and Company Limited est couverte par 9 analystes. 1 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| null null | Asian Markets Securities Private Limited |
| Anil Burra | FirstCall Research |
| Nischint Chawathe | Kotak Securities (Institutional Equities) |